Company news
GeoVax Labs, Inc. news in 2021
GeoVax Labs, Inc.'s news releases, calls and decks from 2021, newest first.
GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
December 14, 2021
GeoVax Announces Upcoming Presentations at Scientific Conferences
November 14, 2021
GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update
November 10, 2021
GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine
November 8, 2021
GeoVax Receives Notice of Allowance for Ebola Vaccine Patent
October 13, 2021
GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
September 27, 2021
GeoVax Reports 2021 Second Quarter Financial Results and Provides Corporate Update
August 10, 2021
GeoVax Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting
July 21, 2021
GeoVax Announces Issuance of Hepatitis B Vaccine Patent
July 6, 2021
GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update
May 5, 2021
GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update
April 25, 2021
GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent
March 31, 2021
GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update
March 22, 2021
GeoVax Expands and Strengthens Intellectual Property Portfolio
March 3, 2021
GeoVax Announces Closing of $10.3 Million Bought Deal Offering
February 10, 2021
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
February 7, 2021
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development
January 10, 2021
Calls in 2021
Decks in 2021
- Q3 2021 Earnings Presentation
Earnings · 24 slides · Nov 12, 2021